Dupont Capital Management Corp cut its position in The Sherwin-Williams Company (NYSE:SHW - Free Report) by 20.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,571 shares of the specialty chemicals company's stock after selling 5,493 shares during the quarter. Dupont Capital Management Corp's holdings in Sherwin-Williams were worth $7,407,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in SHW. Price T Rowe Associates Inc. MD grew its stake in shares of Sherwin-Williams by 21.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company's stock valued at $3,023,126,000 after buying an additional 1,505,341 shares in the last quarter. Nuveen LLC bought a new position in shares of Sherwin-Williams in the first quarter valued at $265,510,000. Assenagon Asset Management S.A. grew its stake in shares of Sherwin-Williams by 601.0% in the second quarter. Assenagon Asset Management S.A. now owns 839,756 shares of the specialty chemicals company's stock valued at $288,339,000 after buying an additional 719,965 shares in the last quarter. National Bank of Canada FI grew its stake in shares of Sherwin-Williams by 223.1% in the first quarter. National Bank of Canada FI now owns 615,375 shares of the specialty chemicals company's stock valued at $214,883,000 after buying an additional 424,930 shares in the last quarter. Finally, Alyeska Investment Group L.P. grew its stake in shares of Sherwin-Williams by 367.9% in the first quarter. Alyeska Investment Group L.P. now owns 537,216 shares of the specialty chemicals company's stock valued at $187,590,000 after buying an additional 422,410 shares in the last quarter. 77.67% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on SHW shares. Evercore ISI lifted their price objective on shares of Sherwin-Williams from $380.00 to $400.00 and gave the stock an "outperform" rating in a research report on Tuesday, August 26th. UBS Group reaffirmed a "buy" rating and set a $400.00 price objective (up from $395.00) on shares of Sherwin-Williams in a research report on Monday, October 6th. Wells Fargo & Company set a $395.00 price objective on shares of Sherwin-Williams and gave the stock an "overweight" rating in a research report on Friday, October 10th. Bank of America reduced their price objective on shares of Sherwin-Williams from $375.00 to $368.00 and set a "neutral" rating for the company in a research report on Tuesday, October 14th. Finally, Mizuho reduced their price objective on shares of Sherwin-Williams from $400.00 to $385.00 and set an "outperform" rating for the company in a research report on Wednesday, July 23rd. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $387.13.
View Our Latest Stock Report on SHW
Insider Transactions at Sherwin-Williams
In other news, CAO James P. Lang sold 860 shares of the business's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $350.35, for a total value of $301,301.00. Following the completion of the sale, the chief accounting officer owned 377 shares of the company's stock, valued at approximately $132,081.95. The trade was a 69.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Justin T. Binns sold 609 shares of the business's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $368.82, for a total value of $224,611.38. Following the completion of the transaction, the insider directly owned 17,922 shares of the company's stock, valued at approximately $6,609,992.04. This trade represents a 3.29% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.60% of the company's stock.
Sherwin-Williams Trading Down 0.0%
Shares of Sherwin-Williams stock opened at $330.72 on Tuesday. The firm has a 50-day moving average of $352.74 and a 200-day moving average of $347.94. The stock has a market cap of $82.46 billion, a PE ratio of 32.81, a PEG ratio of 3.10 and a beta of 1.20. The Sherwin-Williams Company has a 52-week low of $308.84 and a 52-week high of $400.42. The company has a debt-to-equity ratio of 1.78, a quick ratio of 0.48 and a current ratio of 0.78.
Sherwin-Williams (NYSE:SHW - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.76 by ($0.38). The business had revenue of $6.31 billion during the quarter, compared to the consensus estimate of $6.31 billion. Sherwin-Williams had a net margin of 11.03% and a return on equity of 66.91%. The company's revenue was up .6% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.70 EPS. As a group, sell-side analysts forecast that The Sherwin-Williams Company will post 12 EPS for the current year.
About Sherwin-Williams
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Stories
Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.